This month, Prollenium Medical Technologies, Inc. filed its answer and counterclaims to a lawsuit by Allergan …
Diffusion Pharmaceuticals (NASDAQ:DFFN) receives a Notice of Intention to Grant a patent from European Patent …
MaaT Pharma announced today that the Institut National de la Propriété Industrielle (INPI), the French Patent …
The duration of time designated for exclusive use of the new technology or approach was intended to be relativ…
Modern business people work in a matrix of teams and functions. “Rarely are we performing our roles in a vacuu…
On Thursday, May 9, the Affordable Prescriptions for Patients (APP) Act was introduced into the U.S. Senate by…
Intellectual property (IP) is a pharmaceutical or biotech company’s most valuable resource, and its protection…
European parliament approves SPC manufacturing waiver – In its final plenary session prior to the EU elections…
Alembic has recently entered into a Joint Venture Agreement (JVA) with SPH SINE Pharmaceutical Laboratories, C…
Brexit: a quick refresher. We have now passed 29 March 2019 – the day when, absent any extension, the UK was s…
